Deaths involving serotonergic drugs
Tirzepatides unique way of working seems to be more effective
Tirzepatide, a dual GLP-1/GIP receptor agonist approved as Mounjaro for diabetes and Zepbound for weight management, has demonstrated superior efficacy compared to semaglutide in head-to-head trials (SURPASS-2 for diabetes
During research on gut hormones, the medical community discovered that certain substances, in addition to helping control blood sugar, also affect the appetite center in the brain, making the body feel full more easily
The company positions itself as an affordable option for researchers, offering a curated catalog of roughly 30 peptide compounds
Lixisenatide: A new daily GLP-1 agonist for type 2 diabetes management